LAVENTAIR Trademark

Trademark Overview

On Wednesday, June 8, 2016, a trademark application was filed for LAVENTAIR with the United States Patent and Trademark Office. The USPTO has given the LAVENTAIR trademark a serial number of 87064901. The federal status of this trademark filing is REGISTERED as of Tuesday, July 16, 2019. This trademark is owned by Glaxo Group Limited. The LAVENTAIR trademark is filed in the Pharmaceutical Products category with the following description:

Inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory ailments; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
laventair

General Information

Serial Number87064901
Word MarkLAVENTAIR
Filing DateWednesday, June 8, 2016
Status700 - REGISTERED
Status DateTuesday, July 16, 2019
Registration Number5802988
Registration DateTuesday, July 16, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2016

Trademark Statements

Goods and ServicesInhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory ailments; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, August 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 11, 2016NEW APPLICATION ENTERED
Wednesday, June 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 17, 2016ASSIGNED TO EXAMINER
Thursday, May 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 23, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, May 23, 2017SOU EXTENSION 1 FILED
Tuesday, May 23, 2017SOU EXTENSION 1 GRANTED
Tuesday, May 29, 2018SOU EXTENSION 3 FILED
Tuesday, May 29, 2018SOU EXTENSION 3 GRANTED
Tuesday, November 27, 2018SOU EXTENSION 4 FILED
Monday, November 20, 2017SOU TEAS EXTENSION RECEIVED
Monday, November 20, 2017SOU EXTENSION 2 FILED
Monday, November 20, 2017SOU EXTENSION 2 GRANTED
Wednesday, November 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 29, 2018SOU TEAS EXTENSION RECEIVED
Thursday, May 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 27, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, November 27, 2018SOU EXTENSION 4 GRANTED
Monday, June 3, 2019NOTICE OF ALLOWANCE CANCELLED
Wednesday, June 12, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, November 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 17, 2019SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2019SOU EXTENSION 5 FILED
Wednesday, May 22, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 28, 2019SOU EXTENSION 5 GRANTED
Wednesday, May 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 16, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 16, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

laventair preparations pharmaceutical treatment disorders substances diseases respiratory hepatological oncological ophthalmic